<DOC>
	<DOC>NCT00862108</DOC>
	<brief_summary>The purpose of this study is to determine whether norepinephrine gene polymorphism affect to treatment response in ADHD</brief_summary>
	<brief_title>Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>diagnosis made by DSMIV and KSADSPL IQ &gt; 71 genetic disorder history of acquired brain injury seizure disorder other neurologic disorder mental disorder, pervasive developmental disorder obsessiveCompulsive disorder communication disorder learning disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Polymorphism, Single Nucleotide</keyword>
	<keyword>SLC6A2 protein, human</keyword>
	<keyword>ADRA2A protein, human</keyword>
</DOC>